Improvement of the ocular bioavailability of timolol by sorbic acid

被引:36
作者
Higashiyama, M
Inada, K
Ohtori, A
Tojo, K
机构
[1] Senju Pharmaceut Co Ltd, Res Labs, Nishi Ku, Kobe, Hyogo 6512241, Japan
[2] Kyushu Inst Technol, Dept Biochem Sci & Engn, Iizuka, Fukuoka 8208502, Japan
关键词
ocular bioavailability; timolol maleate; ophthalmic solution; ion pair; bilayer diffusion model;
D O I
10.1016/j.ijpharm.2003.11.035
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ocular bioavailability of timolol increased in sorbic acid solution due to ion pair formation. Its octanol/water partition coefficient also increased, suggesting the formation of a more lipophilic complex. The concentration of timolol in rabbit aqueous humor was determined after instillation of timolol ophthalmic solution containing sorbic acid. When the molar ratio of sorbic acid to timolol was two or higher, the concentration of timolol in the aqueous humor was higher than with timolol alone. In the presence of sorbic acid the maximal aqueous humor concentration and the area under the curve were more than two-fold higher than those of Timoptol((R)), a timolol maleate ophthalmic solution, and similar in value to TIMOPTIC-XE(R), a gel-forming ophthalmic solution. To investigate the transcorneal absorption mechanism, in vitro permeation profiles across the intact and de-epithelialyzed cornea were analyzed on the basis of the bilayer diffusion model. The partition coefficient in the epithelium was about twice as high in the presence of sorbic acid than with timolol alone, although the diffusion coefficient in the epithelium did not change. We conclude that the improved ocular bioavailability in the presence of sorbic acid is due to increased partitioning of timolol in the corneal epithelium. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:91 / 98
页数:8
相关论文
共 24 条
[1]  
Akafo S K, 1995, Eur J Ophthalmol, V5, P172
[2]  
ASH M, 2002, PHARM ADDITIVES ELEC
[3]   INFLUENCE OF CORNEAL EPITHELIAL INTEGRITY ON THE PENETRATION OF TIMOLOL PRODRUGS [J].
CHIEN, DS ;
BUNDGAARD, H ;
LEE, VHL .
JOURNAL OF OCULAR PHARMACOLOGY, 1988, 4 (02) :137-146
[4]  
DeSantis Jr LM, 1994, HAVENERS OCULAR PHAR, V22-52
[5]   In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate [J].
El-Kamel, AH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 241 (01) :47-55
[6]   Pharmacokinetic differences between ocular inserts and eyedrops [J].
Friedrich, SW ;
Saville, BA ;
Cheng, YL ;
Rootman, DS .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 1996, 12 (01) :5-18
[7]  
GALLARATE M, 1988, ACTA PHARM TECHNOL, V34, P102
[8]   MICROEMULSIONS AS TOPICAL DELIVERY VEHICLES - OCULAR ADMINISTRATION OF TIMOLOL [J].
GASCO, MR ;
GALLARATE, M ;
TROTTA, M ;
BAUCHIERO, L ;
GREMMO, E ;
CHIAPPERO, O .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1989, 7 (04) :433-439
[9]   CORNEAL PENETRATION BEHAVIOR OF BETA-BLOCKING-AGENTS .2. ASSESSMENT OF BARRIER CONTRIBUTIONS [J].
HUANG, HS ;
SCHOENWALD, RD ;
LACH, JL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (11) :1272-1279
[10]  
*JAP PHARMEXC DIR, 2000, JAP PHARM EXC COUNC